Eprozinol
![]() | |
| Names | |
|---|---|
| IUPAC name
(RS)-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-1-ol | |
| Identifiers | |
| 32665-36-4 | |
| 3D model (Jmol) | Interactive image |
| ChEMBL | ChEMBL2107691 |
| ECHA InfoCard | 100.046.482 |
| KEGG | D07379 |
| PubChem | 122553 |
| UNII | IJ21AK8IVJ |
| |
| Properties | |
| C22H30N2O2 | |
| Molar mass | 354.4858 |
| Pharmacology | |
| R03DX02 (WHO) | |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| | |
| Infobox references | |
Eprozinol is a drug for obstructive airway disease.[1][2]
References
- ↑ Nicrosini, F.; Carpinella, G. (1978). "Eprozinol treatment of chronic bronchitis with dyspnea and cough". Broncho-pneumologie. 28 (4): 322–327. PMID 756799.
- ↑ Labrid, C.; Duchene-Marullaz, P.; Rispat, G. (1981). "Mechanisms of anti-bronchoconstrictive effects of eprozinol. II. In vivo studies on the guinea pig". Pharmacology. 23 (1): 48–55. doi:10.1159/000137526. PMID 7312935.
This article is issued from Wikipedia - version of the 12/16/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
